SCHEMBL721795

SCHEMBL721795

O=C(Nc1ccc(Oc2ccnc3cc(-c4ccccc4)oc23)cc1)c1c(I)ccn(-c2ccc(F)cc2)c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 13/20 0.55
AXL P30530 7/20 0.52
AURKA O14965 1/20 0.45
MST1R Q04912 3/20 0.43
MERTK Q12866 2/20 0.42
TYRO3 Q06418 2/20 0.42
RIPK3 Q9Y572 1/20 0.42
PLK4 O00444 1/20 0.41
ABL1 P00519 1/20 0.41
NTRK1 P04629 1/20 0.41
LCK P06239 1/20 0.41
RET P07949 1/20 0.41
KIT P10721 1/20 0.41
PDGFRA P16234 1/20 0.41
PRKACA P17612 1/20 0.41
KDR P35968 1/20 0.41
FLT3 P36888 1/20 0.41
ABL2 P42684 1/20 0.41
FRK P42685 1/20 0.41
DDR1 Q08345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724084 0.91 MET (0.67) METAXLMST1RMERTKTYRO3
SCHEMBL721614 0.89 AXL (0.60) METAXLMST1RMERTKTYRO3
SCHEMBL721300 0.87 AXL (0.62) METAXLAURKAMERTKTYRO3
SCHEMBL16817176 0.84 AXL (0.47) METAXLAURKAMERTKTYRO3
SCHEMBL723382 0.81 MET (0.58) METAXLMST1RMERTKTYRO3
SCHEMBL723448 0.81 MET (0.69) METAXLMST1RMERTKTYRO3
SCHEMBL16817182 0.81 AXL (0.47) METAXLAURKAMST1RMERTK
SCHEMBL722103 0.79 MET (0.65) METAXLMST1RMERTKTYRO3
SCHEMBL16817179 0.76 MET (0.51) METAXLMERTKTYRO3RIPK3
SCHEMBL16817164 0.73 MET (0.48) METAXLMST1RMERTKTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB MET 1482/4885AXL 390/4885AURKA 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.